ID   ATL-2/ADM cl-1
AC   CVCL_A7QA
DR   Wikidata; Q107113389
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8338 ! ATL-2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
RX   PubMed=9116292; DOI=10.1182/blood.V89.7.2480;
RA   Wang J.-X., Kobayashi M., Sakurada K., Imamura M., Moriuchi T.,
RA   Hosokawa M.;
RT   "Possible roles of an adult T-cell leukemia (ATL)-derived
RT   factor/thioredoxin in the drug resistance of ATL to adriamycin.";
RL   Blood 89:2480-2487(1997).
//